Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP646609.RAsD7xQdNbbtUrWK56WOB7LUikf6NjYa93zzcmvAT_Gl0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP646609.RAsD7xQdNbbtUrWK56WOB7LUikf6NjYa93zzcmvAT_Gl0130_assertion type Assertion NP646609.RAsD7xQdNbbtUrWK56WOB7LUikf6NjYa93zzcmvAT_Gl0130_head.
- NP646609.RAsD7xQdNbbtUrWK56WOB7LUikf6NjYa93zzcmvAT_Gl0130_assertion wasGeneratedBy ECO_0000203 NP646609.RAsD7xQdNbbtUrWK56WOB7LUikf6NjYa93zzcmvAT_Gl0130_provenance.
- NP646609.RAsD7xQdNbbtUrWK56WOB7LUikf6NjYa93zzcmvAT_Gl0130_assertion wasDerivedFrom befree-20140225 NP646609.RAsD7xQdNbbtUrWK56WOB7LUikf6NjYa93zzcmvAT_Gl0130_provenance.
- NP646609.RAsD7xQdNbbtUrWK56WOB7LUikf6NjYa93zzcmvAT_Gl0130_assertion SIO_000772 23293110 NP646609.RAsD7xQdNbbtUrWK56WOB7LUikf6NjYa93zzcmvAT_Gl0130_provenance.
- NP646609.RAsD7xQdNbbtUrWK56WOB7LUikf6NjYa93zzcmvAT_Gl0130_assertion evidence source_evidence_literature NP646609.RAsD7xQdNbbtUrWK56WOB7LUikf6NjYa93zzcmvAT_Gl0130_provenance.
- NP646609.RAsD7xQdNbbtUrWK56WOB7LUikf6NjYa93zzcmvAT_Gl0130_assertion description "[Combined analysis for DFS and OS indicated that patients with the fewest number of favorable genotypes simultaneously present (VEGFR-2 -906 T/T, CXCR-2 +1208 C/T or C/C and PAR-1 -506 Del/Del) were at the highest risk for recurrence or death (P < 0.0001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP646609.RAsD7xQdNbbtUrWK56WOB7LUikf6NjYa93zzcmvAT_Gl0130_provenance.